![China has issued a series to regulations and reforms over the past year to address doubts about the ethical integrity of its biotechnology sector after a Chinese scientist said he had used gene-editing technology to engineer twins with immunity to HIV. This Dec. 26, 2018, photo shows a researcher working in a Beijing Genomics Institute laboratory in Kunming, China.](https://www.stratfor.com/sites/default/files/styles/article_large/public/China-Biotech-DISPLAY.jpg?itok=v6mJ8OCR)
A researcher works in a Beijing Genomics Institute laboratory in Kunming, China, on Dec. 26, 2018. China has publicized a series of new regulations since a Chinese scientist claimed to have genetically engineered twins last year, but has not accounted for the scientist’s alleged feat.
(Visual China Group via Getty Images)
Beijing has made a point of publicizing legal changes since a Chinese scientist claimed to have genetically engineered twins last year, but it’s not clear how effective the reforms will be without a full accounting of the scandal….
TO READ THE FULL ARTICLE
Continue reading your article with a Stratfor Worldview subscription. |
Preview Some FREE Worldview Articles Below:
Connected Content
Regions & Countries
Copyright © Stratfor Enterprises, LLC. All rights reserved.